High Throughput Screening for Genetic Analysis of Colorectal Cancer Risk

CSIRO, Australia0 sites300 target enrollmentSeptember 2, 2005

ConditionsBowel Cancer Cancer - Bowel - Anal Cancer - Bowel - Back passage (rectum) or large bowel (colon)Cancer - Bowel - Small bowel (duodenum and ileum

Overview

Phase: N/A
Intervention: Not specified
Conditions: Bowel Cancer
Sponsor: CSIRO, Australia
Enrollment: 300
Status: Completed
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

September 2, 2005

End Date

TBD

Last Updated

6 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

CSIRO, Australia

Eligibility Criteria

Inclusion Criteria

•Cancer patients:1: Patients from families with 3 or more first\-degree relatives having CRC, with one diagnosed less than 50 years of age. 2: Patients from families with 2 or more first\-degree relatives having CRC. 3: Patients from families with one first degree and one or more second\-degree relatives having CRC.Unaffected Individuals:1: First\-degree relatives, over 70 years of age, from the above families who have no history of colorectal neoplasia.2:Younger first\-degree relatives, at least 50 years of age, who are colonoscopy negative.

Exclusion Criteria

•No exclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

N/A

Research on genomic test utilizing next generation sequencer for solid tumors and development of the genome database

JPRN-UMIN000028388iigata University995

Recruiting

N/A

The PersOnalising gEneTIc Counselling (POETIC) Trial: Testing the implementation and effectiveness of an intervention to personalise genetic counsellingInherited predisposition to cancerHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersCancer - Any cancer

ACTRN12621001582842Peter MacCallum Cancer Centre246

Recruiting

N/A

Genetic screening of an at-risk population for Hereditary TransthyRetin-related AMyloidosis and longitudinal monitoring of TTR positive subjects

DRKS00016158Centogene AG Rostock5,000

Completed

N/A

TLA Technology: a new DNA diagnostic test to sequence genes that cause the disease and detect new mutations: proof of concept study voor patients with Rendu-Osler-Weber disease.Rendu-Osler-Weber hereditary hemorrhagic telangiectasia10007510

NL-OMON39779Sint Antonius Ziekenhuis45

Recruiting

N/A

Genome sequence and gene expression analysis using formalin-fixed paraffin-embedded samples of gastrointestinal epithelial tumors and elucidation of the mechanism of gastrointestinal epithelial tumor development using immunostaining and in situ hybridizatio

JPRN-UMIN000047223The University of Tokyo500